Dublin, May 27, 2021 (GLOBE NEWSWIRE) -- The "Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care" report has been added to ResearchAndMarkets.com's offering.
This GO-TE studies some of the path breaking innovators in this space and their technology readiness levels. The report also discusses the funding, partnerships, and emerging growth opportunities.
The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission.
This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their share of drawbacks including invasive profile and therapy-related complications, that have necessitated the development of novel neuromodulation methods that can provide effective relief from mental disorders for the patients, while at the same time are non-invasive, safe, and tolerable.
This growth opportunity-technology (GO-TE) report highlights the innovations in non-invasive neuromodulation technologies being implemented for treating mental health conditions, including transcranial electrical stimulation, transcranial magnetic stimulation, cranial electrotherapy stimulation and other therapies such as transcutaneous vagus nerve stimulation, trigeminal nerve stimulation, and multi-channel simultaneous stimulation.
Key Topics Covered:
1. Executive Summary
1.1 Scope of the Research
1.2 Research Methodology
2. Industry Overview
2.1 Growing Burden of Mental Health Disorders Globally
2.2 Neuromodulation Techniques Address the Limitations of Drug-based and Psychotherapy Methods for Managing Mental Disorders
2.3 Drawbacks of Traditional Neuromodulation Methods are Hindering their Wide-spread Adoption
2.4 Technology Segmentation for Emerging Neuromodulation Therapies
2.5 Transcranial Electrical Stimulation Enabling Neuromodulation of Specific Cortical Regions of the Brain
2.6 Transcranial Magnetic Stimulation Facilitates Neuromodulation of Wide and Deeper Subcortical Structures in the Brain
2.7 Enabling Neuromodulation of Cortical and Subcortical Areas in the Brain through Cranial Electrotherapy Stimulation
2.8 Neuromodulation of Vagus, Occipital, and Trigeminal Nerve for Treating Mental Disorders
2.9 Application Analysis: Increasing Application Areas Offer Lucrative Growth Opportunities for Companies Developing Emerging Neuromodulation Technologies
2.10 Benchmarking Rubrics
2.11 Impact of TMS to be Relatively High as Compared to Other Emerging Neuromodulation Technologies
3. Companies to Action
3.1 Transcranial Direct Current Stimulation System for Managing Depression
3.2 Other Notable Transcranial Direct Current Stimulation Systems for Treating Depression
3.3 Transcranial Magnetic Stimulation System for Managing Depression and Obsessive-compulsive Disorder
3.4 Other Notable Transcranial Magnetic Stimulation Systems for Depression Treatment
3.5 Over-ear Headphone-based Cranial Electrotherapy Stimulator Device for the Treatment of Anxiety, Depression, and Insomnia
3.6 Other Notable Cranial Electrotherapy Stimulation Systems for Treating Anxiety and Depression
3.7 External Trigeminal Nerve Stimulation System for Treating Attention-deficit/Hyperactivity Disorder in Patients
3.8 Other Notable Non-invasive Vagus Nerve Stimulation and Multi-channel Brain Neuromodulation Systems for Managing Mental Disorders
4. Funding and Partnerships Assessment
4.1 Analysis of National Institutes of Health (NIH) Funding for Emerging Neuromodulation Technologies
4.2 Funding Assessment for Emerging Neuromodulation Technologies
4.3 Partnerships between Mental Health Companies and Health Providers for Improving Access to Neuromodulation Therapies
4.4 Acquisitions by Mental Health Neuromodulation Participants for Improving Intellectual Property and Product Portfolio
5. Growth Opportunities and Patent Analysis
5.1 Growth Opportunity: Emerging Neuromodulation Technology Innovations, 2020
5.2 Growth Opportunity 1: Distance Health Facilitated through Wearable-enabled Neuromodulation Therapies
5.3 Growth Opportunity 2: Incorporating Artificial Intelligence into Neuromodulation Systems for Providing Smart Therapy
5.4 Growth Opportunity 3: Partnerships between Non-invasive Neuromodulation Therapy Companies and Specialized Mental Health Providers to Improve Access to Underserved Populations
5.5 Patent Scenario-Key Patents for Transcranial Magnetic Stimulation Systems
5.6 Patent Scenario-Key Patents for Transcranial Electrical Stimulation and Trigeminal Nerve Stimulation Systems
6.0 Key Contacts
For more information about this report visit https://www.researchandmarkets.com/r/6xh3kv